Researchers analyzed global trends in multidrug-resistant tuberculosis (MDR-TB) among children and adolescents, revealing ...

This innovative program addresses global health initiatives and medical training in Peru with Partners in Health, known ...

BV500 reaches second milestone, with the advancement of multiple broadly profiled and highly potent oral Lead candidates with demonstrated broad-spectrum in vitro and in vivo efficacy against ...

The global research agenda includes 33 research priorities for bacterial and fungal infections and 7 for drug-resistant ...

A series of reports released today by the European Centre for Disease Prevention and Control (ECDC) show sexually transmitted ...

Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of ...

Drug resistance in Mycobacterium tuberculosis arises from the man-made selection of mutants that result from spontaneous chromosomal alterations. Preventing the development of drug-resistant TB ...

Introduction Globally, tuberculosis (TB) remains one of the leading infectious causes of death, with 1.3 million deaths.

According to the officials, the new regimen, called BPaL/BPaLM, includes medications bedaquiline, pretomanid, linezolid, and ...

With cases of drug-resistant tuberculosis on the rise again around the world, GSK has sparked hopes of a new treatment option after reporting phase 2a data with a novel antitubercular drug for the ...

We’ll avoid that fight and instead focus on why the public, with the FDA’s help, has misunderstood why so many Americans die from resistant infections every year. In short: The Food and ...